EU Panel Recommends Humira Biosimilars Idacio, Kromeya

The EMA's Committee for Medicinal Products for Human Use has recommended marketing authorization for two biosimilars that are highly similar to Humira (adalimumab, AbbVie).
International Approvals

https://wb.md/2D1lYMy